Edge Rewrite
everything Source code View original
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a43355d42984addf

Jump to content

Tata 1mg

Add links
From Wikipedia, the free encyclopedia
(Redirected from 1mg)

TATA 1mg
TypePrivate
Industry
Founded2015; 11 years ago (2015)
FounderPrashant Tandon
Gaurav Agarwal
Vikas Chauhan
Headquarters
Gurugram, Haryana
,
India
Area served
India
Key peoplePrashant Tandon (CEO)
Gaurav Agarwal (CTO)
Vikas Chauhan
Tanmay Saksena (COO)[1]
ProductsMedicine Supply
Healthcare Products
Services
RevenueIncrease ₹1,968 crore (US$200 million) (2024) [2]
Positive decrease ₹−313 crore (US$−33 million) (2024)
Number of employees
800+ (2021)[3]
ParentTata Digital

Tata 1mg, formerly known as 1mg,[4] is an Indian digital healthcare company headquartered in Gurugram, Haryana. The company provides integrated healthcare services—including e-pharmacy, e-diagnostics, and tele-consultation—through a digital platform and a growing network of physical retail pharmacies and diagnostic laboratories across India.[5][6]

It was founded in April 2015 by Prashant Tandon, Gaurav Agarwal, and Vikas Chauhan.[5][7] the company has since expanded to include speciality care services covering cancer care,[8][9] obesity management, and at-home adult vaccination, along with private label health and nutrition products and corporate health and wellness programmes.[10][11]

History

[edit]

In 2012, Bright Lifecare Private Limited launched a digital health platform called HealthkartPlus.[12] In 2015, HealthkartPlus was spun off to form 1MG Technologies Private Limited.[13] Healthkart continued as a separate entity focused on fitness and nutrition products; while 1mg operated as a generic drug search and price comparison platform.[14]

The company subsequently developed an online medicine database providing information on drug usage, side effects and generic substitutes, and expanded into home delivery of prescription and over-the-counter medicines as well as diagnostic testing services.[15]

In June 2021, Tata Digital Ltd. acquired a majority stake of approximately 55% in 1mg, after which the platform was rebranded as Tata 1mg and integrated into the Tata Group's digital ecosystem.[16]

In 2023, Tata 1mg was reported to hold approximately 31% of the Indian e-pharmacy market by GMV, making it the largest e-pharmacy platform in India at that time.[17]

In 2024, Tata 1mg and Vitonnix UK jointly introduced Vitamin Sublingual Sprays in Indian market. The first phase of the launch includes vitamin D, multivitamins, biotin, and melatonin.[18]

In December 2025, the company reported positive EBITDA across its core business lines.[6]

Services

[edit]

Tata 1mg provides healthcare services through an omnichannel model, combining a digital platform with a network of physical retail pharmacies and diagnostic laboratories.[6]

ePharmacy

Tata 1mg's e-pharmacy service enables users to order prescription medicines, over-the-counter products, and healthcare essentials.[19] Medicines are sourced from licensed manufacturers and authorised distributors. As of 2026, the service covers more than 20,000 pin codes across India.[6]

eDiagnostics

Tata 1mg's diagnostics service provides home sample collection and laboratory testing through a network of NABL-accredited laboratories.[8] The company operates a National Reference Laboratory in Okhla, New Delhi, which holds accreditation from the College of American Pathologists (CAP).[8]

Retail Pharmacies

Tata 1mg operates a network of physical retail pharmacies across India. As of 2026, the company operates more than 280 retail pharmacy outlets,[6] with plans to expand to approximately 500 outlets by the end of the year.[20]

Specialty Pharma

Tata 1mg offers speciality care services spanning cancer care, obesity management, and at-home adult vaccination, available across multiple cities in India.[8][9][21] These services are designed to support patients requiring ongoing therapy management and access to specialty medicines.

Partnership

[edit]

In March 2022, Tata 1mg made a strategic investment in 5C Network for an undisclosed amount.[22] In May 2025, Tata 1mg partnered with Unicommerce to enhance its e-commerce efficiency across over 1,000 cities in India. The collaboration involved the integration of Unicommerce’s SaaS technology to automate multi-channel order management and warehouse operations.[23]

See also

[edit]

References

[edit]
  1. ↑ Chakraborty, Sayan (3 May 2016). "1mg Technologies appoints former Zomato executive Tanmay Saksena as COO". mint.
  2. ↑ "Tata 1mg FY24 results". 27 August 2024.
  3. ↑ "1mg". Retrieved 6 July 2021.
  4. ↑ "Tata Digital to acquire majority stake in 1MG". The Hindu. 11 June 2021. ISSN 0971-751X. Retrieved 16 August 2021.
  5. 1 2 Narasimhan, T. E. (1 March 2019). "Digital healthcare platform IMG Technologies to raise $70 million". Business Standard India. Retrieved 16 August 2021.
  6. 1 2 3 4 5 www.ETPharma.com. "Tata 1mg turns Ebitda positive across operations; plans retail network expansion". ETPharma.com. Retrieved 16 June 2026.
  7. ↑ Sil, Debarghya (4 November 2020). "Online Medical and Healthcare Platform 1mg Appoints Mayank Gupta as CFO". Entrepreneur. Retrieved 16 August 2021.
  8. 1 2 3 4 "Tata 1mg turns Ebitda positive across core units as diagnostics crosses Rs 600 crore in ARR". The Economic Times. 27 May 2026. ISSN 0013-0389. Retrieved 16 June 2026.
  9. 1 2 "A Prescription Of Trust | Tata group". www.tata.com. Retrieved 16 June 2026.
  10. ↑ Sarkar, Subhojit (27 May 2026). "Tata 1mg turns Ebitda positive across all core businesses in FY26". Fortune India. Retrieved 16 June 2026.
  11. ↑ Livemint (27 January 2022). "Mahindra Insurance Brokers partners Tata 1mg for wellness solutions | Company Business News". mint. Retrieved 16 June 2026.
  12. ↑ Narasimhan, T. E. (1 March 2019). "Digital healthcare platform IMG Technologies to raise $70 million". Business Standard India. Retrieved 26 July 2021.
  13. ↑ Verma, Shrutika (20 April 2015). "Healthkart gets $6 million for spun-off 1MG". mint. Retrieved 26 July 2021.
  14. ↑ "Healthkart Separates & Rebrands HealthkartPlus To 1MG, Gets $6 Mn For The Newly Formed Entity". Inc42 Media. 20 April 2015. Retrieved 16 August 2021.
  15. ↑ www.ETRetail.com. "Tata 1mg turns EBITDA positive across core units as diagnostics crosses Rs 600 cr in ARR". ETRetail.com. Retrieved 13 July 2026.
  16. ↑ "E-health Startup 1mg Gets A $15 Million Booster Dose In Funding". Forbes India. Retrieved 16 August 2021.
  17. ↑ Web Team, BS (16 November 2023). "Tata 1mg overtakes PharmEasy as leaders in India's e-pharmacy market". Business Standard.
  18. ↑ "Tata 1mg & Vitonnix UK enter exclusive partnership in India". The Statesman. 10 January 2024. Retrieved 10 January 2024.
  19. ↑ Jani, Jessica (8 November 2024). "A prescription for speed: How e-pharmacies aim to transform medicine delivery". mint. Retrieved 4 August 2026.
  20. ↑ "Tata 1mg Announces Major Expansion With Nearly 500 Offline Stores Nationwide". Digital Health News. Retrieved 4 August 2026.
  21. ↑ Sarkar, Subhojit (27 May 2026). "Tata 1mg turns Ebitda positive across all core businesses in FY26". Fortune India. Retrieved 4 August 2026.
  22. ↑ "Tata1mg makes strategic investment in diagnostic platform 5C Network | Company Business News". mint. 16 March 2022. Retrieved 5 June 2026.
  23. ↑ "Tata 1mg partners with Unicommerce to boost e-commerce efficiency across 1000 cities". MediaBrief. 21 May 2025. Retrieved 8 June 2025.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Tata_1mg&oldid=1369680539"